Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...

With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...

With that as the backdrop, here's a closer look at three names that could be worth more than Berkshire Hathaway just five ...

Mounjaro (tirzepatide) is a prescription drug used to ... Your doctor will likely have you start treatment with a 2.5-mg dose of Mounjaro. After 4 weeks of treatment, they’ll increase your ...

See which services passed our rigorous vetting process. Share on Pinterest Mounjaro (tirzepatide) is an injectable medication that’s approved for diabetes by the Food and Drug Administration (FDA).

The company sells tirzepatide, approved for weight loss ... Morgan Stanley Research predicts the obesity drug market may surpass $100 billion by the end of the decade. So, by investing in Lilly ...

And analyst forecasts suggest ongoing momentum: Morgan Stanley Research predicts the obesity drug market may surpass $100 billion by the end of the decade. So, by investing in Lilly, you'll ...

The Renault 5 isn’t the first car from a bygone era to make a comeback, but we reckon it could prove just as successful as other efforts (including the reimagined Fiat 500 and Mini). Indeed ...

Read on to learn everything we know about Fallout 5. If you've ever played a Fallout game, you'll know the series revels in its nuclear-ravaged American setting. Fallout games have all been set in ...

If anything could threaten Novo Nordisk's ambitions in this area, it is likely to be tirzepatide. In SURMOUNT-1, patients taking a weekly injection of the drug saw an average 22.5% reduction in ...

The content and materials featured on this page are for educational purposes only. Lightchain AI eyes a $5 surge as its presale hits $10.6M, outshining Cardano’s $3.10 recovery goal for 2025. The ...